Sign in

Kevin R.M. Smith

Chief Executive Officer at Inogen
Board
Since November 10, 2023
Age
54 years
Education
Holds a Master of Business Administration (MBA) in Global Management from the University of Phoenix and a Bachelor of Science (B.S.) in Marketing from the University of Kentucky.
Tenure
Joined INGN on November 10, 2023, as Chief Executive Officer, President, and Director, succeeding the previous leadership.

Also at Inogen

GR
Gregoire Ramade
Executive Vice President, Chief Commercial Officer
MB
Michael Bourque
Executive Vice President, Chief Financial Officer, and Corporate Treasurer

About

Kevin R.M. Smith is a seasoned executive with extensive experience in the medical device and biotechnology industries, having held several senior leadership roles over the past two decades.

He advanced his career through roles at various organizations, including serving as Executive Vice President of Sales & Marketing at Sirtex Medical Limited and as Interim President and CEO at OncoSec Medical, Inc., among others.

At INGN, he joined on November 10, 2023, and assumed the roles of Chief Executive Officer, President, and Director, where he is tasked with driving the company’s growth and operational strategy.

His background is further complemented by his academic achievements, holding an MBA in Global Management and a BS in Marketing, which have underpinned his success in transforming businesses and leading global expansions.

$INGN Performance Under Kevin R.M. Smith

Past Roles

OrganizationRoleDate RangeDetails
Sirtex Medical Limited CEO, President, and Executive Director April 2019 to November 2023 Promoted from previous role; also provided executive leadership
OncoSec Medical, Inc. Interim President, CEO and Director December 2021 to April 2022 Also served on the Board of Directors from 2020 to 2023
Sirtex Medical Limited Executive Vice President of Sales & Marketing, Americas 2017 to 2019 Role transitioned prior to CEO appointment
Gel-e, Inc. Executive Vice President of Business Development N/A [N/A]N/A
Sensium Healthcare Chief Commercial Officer N/A [N/A]N/A
Teleflex Global Vice President of Sales & Marketing N/A [N/A]N/A

Fixed Compensation

Data from  FY 2024
Component NameAmountPayment ScheduleAdditional Details
Salary$700,000 AnnualBase Salary
Bonus$850,000 AnnualCash Bonus
Time-Based RSUs$597,125; 85,000 RSUs 3-year VestingVests in one-third increments: first vesting on March 1, 2024 then annually
All Other Compensation$6,600 AnnualIncludes benefits and perquisites; further details not specified

Performance Compensation

Data from  FY 2024

Performance-Based RSUs

MetricDetails
Performance MetricRelative Total Shareholder Return (TSR) vs. S&P 1000 Health Care Equipment Select Industry
Threshold25th percentile for 50% of target RSUs
Target50th percentile for 100% of target RSUs
Maximum60th percentile for 120% of target RSUs
Vesting ScheduleEarned over 3 years; vesting occurs by linear interpolation; if change in control, vest immediately
Evaluation PeriodThrough December 31, 2026
Grant DateApril 4, 2024
Grant Date Fair Value$589,900
Number of RSUs85,000

Non-Equity Incentive Plan Compensation

MetricThresholdTargetMaximumActual AchievementWeight
Revenue ($USD M)$310.9 M $327.2 M $335.4 M $335.7 M (200% achievement) 50%
Adjusted EBITDA ($USD M)($19.5 M) ($18.6 M) ($15.5 M) ($4.9 M) (200% achievement) 50%
DetailInformation
Target Annual Cash Incentive$700,000
Maximum Annual Cash Incentive$1,400,000
Actual Annual Cash Incentive Paid$1,410,000
Grant Date for AwardsFebruary 14, 2024
Grant Date Fair Value (Stock Awards)$1,187,025
Grant Date Stock Price$9.17 per share (closing price on December 31, 2024)

This section consolidates the performance compensation details for 2024, including both the performance-based RSUs and the non-equity incentive plan components.